Etiology and functional status of liver cirrhosis by 31P MR spectroscopy

Table 1 Concentrations of ³¹P visible metabolites (mmol/L) in the liver according to the degree of liver injury

	n	PME	Pi	PDE	ATP
Controls	11	3.09±1.45	1.63±0.55	10.83±2.68	3.72±0.99
All patients	80	3.53±1.45	1.33±0.61	7.16±2.88d	2.95±0.84b
CPS-A	18	3.64±1.68	1.37±0.56	9.16±2.32	3.24±0.85
CPS-B	25	3.60±1.31	1.31±0.57	7.31±2.62d	2.93±0.78a
CPS-C	37	3.44±1.46	1.33±0.66	6.07±2.80df	2.83±0.87b

^aP<0.05,

^bP<0.01,

^dP<0.001 vs the control group;

^fP<0.01 vs the CPS-A group.